Synthetic Cannabinoids – Harms and general risk By Dr Raimondo Bruno
Dr. Raimondo Bruno is an Associate Professor in the School of Medicine at the University of Tasmania. His main research interests include the cognitive consequences of use of medications and illicit drugs; illicit drug market trends; and approaches to reduce the harms associated with substance use. He has active research collaborations with key national research centres in the substance use field and holds conjoint positions at Turning Point Alcohol and Drug Centre, and the National Drug and Alcohol Research Centre, University of New South Wales.
• Benzodiazepines have proved successful for anxiety, panic, and agitation.
• There have been a number of high impact outbreaks in recent years.
• All clinicians should be aware of NEPTUNE clinical guidance for management.